Cita APA (7a ed.)

Valdés-Mora, F., Gould, C. M., Colino-Sanguino, Y., Qu, W., Song, J. Z., Taylor, K. M., . . . Clark, S. J. (2017). Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Valdés-Mora, Fátima, et al. Acetylated Histone Variant H2A.Z Is Involved in the Activation of Neo-enhancers in Prostate Cancer. Nature Portfolio, 2017.

Cita MLA (8a ed.)

Valdés-Mora, Fátima, et al. Acetylated Histone Variant H2A.Z Is Involved in the Activation of Neo-enhancers in Prostate Cancer. Nature Portfolio, 2017.